Supported HBPM Program for High Blood Pressure
(MonitorBP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to consult with the trial coordinators or your doctor for guidance.
What data supports the effectiveness of the Supported HBPM program for high blood pressure?
Research shows that home blood pressure monitoring (HBPM) is effective in managing high blood pressure, especially when combined with structured education and support. Studies indicate that HBPM, along with physician recommendations, can lead to better blood pressure control and medication adherence.12345
Is home blood pressure monitoring (HBPM) safe for managing high blood pressure?
How is the Supported HBPM program for high blood pressure different from other treatments?
The Supported HBPM program is unique because it combines home blood pressure monitoring with a multifaceted strategy, potentially including mobile apps and pharmacist support, to improve blood pressure control and medication adherence. This approach is more comprehensive than traditional methods, which may not integrate technology and personalized support.410111213
What is the purpose of this trial?
This trial aims to see if a supported home blood pressure monitoring program can help patients with uncontrolled hypertension manage their condition better. The program provides tools and support for patients to measure their blood pressure at home and share the results with their doctors. The goal is to improve blood pressure control by making it easier for doctors to monitor and adjust treatments. Home blood pressure monitoring is a self-monitoring tool recommended by major guidelines and supported by evidence for its benefits in improving blood pressure control.
Research Team
Ian Kronish, MD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for adults aged 18-85 with high blood pressure who are patients at certain New York medical practices, including those specializing in HIV medicine. They must have had a primary care visit within a specific timeframe and cannot participate if they have advanced dementia, frailty, pregnancy, stage 5 kidney disease, terminal illness or if their medical director opts out.Inclusion Criteria
Exclusion Criteria
Timeline
Pre-Implementation
Data is retrospectively collected from a 12-month period before implementation to assess baseline outcomes
Implementation
Implementation of the Supported HBPM program across practices, with intervention clinics receiving access to the program and control clinics continuing usual care
Follow-up
Participants are monitored for changes in blood pressure and medication adherence after the implementation period
Treatment Details
Interventions
- Supported HBPM program plus multifaceted implementation strategy
- Usual care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Weill Medical College of Cornell University
Collaborator
New York Presbyterian Hospital
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator